SGLT-2 inhibitors for COVID-19 - A miracle waiting to happen or just another beat around the bush?

Chatterjee, Subhankar

Chatterjee, Subhankar.

Chatterjee S; Department of General Medicine, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India. Electronic address: chatterjeeaspiresubhankar.92@gmail.com.

Prim Care Diabetes ; 14(5): 564-565, 2020 10.

Article in English | MEDLINE | ID: covidwho-401639

Subject(s)

Betacoronavirus; Blood Glucose/drug effects; Coronavirus Infections/drug therapy; Pneumonia, Viral/drug therapy; Sodium-Glucose Transporter 2 Inhibitors/therapeutic use; Blood Glucose/metabolism; COVID-19; Coronavirus Infections/blood; Coronavirus Infections/epidemiology; Humans; Pandemics; Pneumonia, Viral/blood; Pneumonia, Viral/epidemiology; Prognosis; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Blood Glucose / Coronavirus Infections / Betacoronavirus / Sodium-Glucose Transporter 2 Inhibitors Type of study: Observational study / Prognostic study Limits: Humans Language: English Journal: Prim Care Diabetes Journal subject: Endocrinology Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google